Welcome to our dedicated page for Phreesia news (Ticker: PHR), a resource for investors and traders seeking the latest updates and insights on Phreesia stock.
Phreesia reports developments tied to its patient activation platform for healthcare providers, life sciences companies and other organizations. The company’s recurring news includes quarterly results, stakeholder letters, patient intake, outreach, education and appointment-scheduling solutions, and the scale of patient visits enabled through its digital workflows.
Company updates also cover healthcare payment capabilities, including the completed AccessOne acquisition, credit-facility refinancing, and corporate governance or workplace recognition items. Phreesia’s news flow is centered on software, payments and engagement tools used across healthcare delivery and patient interactions.
Phreesia (NYSE:PHR) and March of Dimes have formed a partnership to strengthen physician-patient conversations during prenatal and postpartum care across the U.S. The collaboration delivers March of Dimes’ evidence-based educational content to pregnant patients, new parents and caregivers, along with complementary resources for their healthcare providers just before relevant appointments.
The campaign focuses on three key maternal and infant health issues: preeclampsia, postpartum depression recognition and resources, and safe sleep practices for infants. By simultaneously equipping patients and providers, the initiative is designed to align messages, support shared decision-making and ultimately improve maternal and infant health outcomes.
Phreesia (NYSE:PHR) announced that MediFind, its data-powered online provider directory, has launched Chloe, an AI-enabled “Find the Right Provider” chatbot. Chloe guides patients through a short conversational intake on MediFind.com, collecting details such as care needs, location, insurance and personal preferences.
According to Phreesia, Chloe uses MediFind’s database of more than 2 million clinicians to surface tailored provider matches that patients can review, compare and then use to request appointments directly through the platform, with a focus on complex, chronic and rare conditions.
Phreesia (NYSE:PHR) reported Q1 fiscal 2027 results for the quarter ended April 30, 2026. Total revenue was $130.9M, up 13% year-over-year, with 4,708 AHSCs (+7%) and revenue per AHSC of $27,811 (+6%).
Net income was $3.0M versus a $3.9M loss, Adjusted EBITDA was $30.5M, operating cash flow was $23.9M and free cash flow was $16.4M. Phreesia refinanced into a new $275M revolver, expanded AccessOne’s securitization facility to $300M, and maintained fiscal 2027 guidance for revenue of $510–$520M and Adjusted EBITDA of $125–$135M.
Phreesia (NYSE: PHR) will release fiscal first quarter 2027 results after market close on Wednesday, May 27, 2026. A press release and a quarterly stakeholder letter will be posted at the company investor website, followed by a live conference call and webcast at 5:00 PM ET.
Dial (833) 461-5787 or (626) 884-3620 (international) with conference code 953036497. A replay will be available on the same investor page for approximately 90 days. Phreesia reported enabling more than 180 million patient visits in 2025.
Phreesia (NYSE: PHR) was named to Becker’s Hospital Review’s 2026 list of “Revenue Cycle Management Companies to Know” on April 14, 2026. The recognition highlights Phreesia’s patient intake, payment and workflow tools that digitize intake, centralize payment processing and aim to improve collections and reduce manual work.
MediFind (NASDAQ: PHR) announced it received the DiMe Seal from the Digital Medicine Society on April 9, 2026, becoming the first doctor directory awarded this independent digital health trust mark. DiMe evaluates platforms on clinical evidence, privacy and security, and usability.
Phreesia acquired MediFind in July 2023. The seal aims to help consumers identify higher‑trust digital health tools when searching for specialists, including rare disease care.
Phreesia (NYSE: PHR) reported fiscal 2026 results with revenue of $480.6M (up 14% YoY), GAAP net income of $2.3M, Adjusted EBITDA $101.5M, and free cash flow of $54.4M. Q4 revenue was $127.1M (+16% YoY) and Q4 Adjusted EBITDA was $29.4M.
The company completed the AccessOne acquisition for ~$164M and refinanced debt with a new five-year $275M Capital One facility. Phreesia lowered fiscal 2027 revenue guidance to $510M–$520M but maintained Adjusted EBITDA guidance of $125M–$135M.
Phreesia (NYSE: PHR) was named one of Becker’s Healthcare Top Places to Work in Healthcare 2026, marking its second appearance on the list. As an all‑remote employer, Phreesia highlights competitive pay, flexible time off, home‑office support, parental benefits and professional development programs.
The company reported enabling approximately 170 million patient visits in 2024, and emphasizes employee resource groups, wellness programs and connection as part of its people strategy.
Phreesia (NYSE:PHR) and Sesame Workshop won the Point of Care Excellence Award at POCMA’s POC Now Summit on March 18, 2026 for their pediatric health and wellness campaign.
The partners launched a six-part campaign in October 2025 after announcing a five-year collaboration in August 2025. Early metrics show 64% of parents found the Sesame Street content very helpful and 91% said it was easy to understand.
Phreesia (NYSE: PHR) entered a new senior secured revolving credit facility of up to $275 million with Capital One as agent and borrowed approximately $92.2 million at closing to repay and terminate its prior bridge loan without penalty.
The new facility replaces a prior $50 million asset-based revolver and can be used for working capital, capex, permitted acquisitions and general corporate purposes; the company said the refinancing reduces borrowing costs and improves financial flexibility.